The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk

被引：0
|
作者：
Irene Catucci
Paolo Radice
Roger L. Milne
Fergus J. Couch
Melissa C. Southey
Paolo Peterlongo
机构：
[1] IFOM,Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine
[2] Fondazione Istituto FIRC di Oncologia Molecolare,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[3] Fondazione IRCCS Istituto Nazionale dei Tumori,Genetic Epidemiology Laboratory, Department of Pathology
[4] Cancer Epidemiology Centre,undefined
[5] Cancer Council Victoria,undefined
[6] University of Melbourne,undefined
[7] Department of Laboratory Medicine and Pathology,undefined
[8] Mayo Clinic,undefined
[9] The University of Melbourne,undefined
来源：
Breast Cancer Research | / 18卷
关键词：
Breast cancer predisposition; Breast cancer genetic risk factor; p.Leu939Trp; VUS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PALB2 mutations in familial breast and pancreatic cancer
    Erin W. Hofstatter
    Susan M. Domchek
    Alexander Miron
    Judy Garber
    Molin Wang
    Kathryn Componeschi
    Leigh Boghossian
    Penelope L. Miron
    Katherine L. Nathanson
    Nadine Tung
    Familial Cancer, 2011, 10 : 225 - 231
  • [42] PALB2 MUTATIONS IN HIGH-RISK WOMEN WITH OVARIAN OR BREAST CANCER
    Metcalfe, K.
    Lerner-Ellis, J.
    Akbari, M.
    Narod, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1594 - 1594
  • [43] Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer
    Toh, Ming Ren
    Low, Chen Ee
    Chong, Siao Ting
    Chan, Sock Hoai
    Ishak, Nur Diana Binte
    Courtney, Eliza
    Kolinjivadi, Arun Mouli
    Rodrigue, Amelie
    Masson, Jean-Yves
    Ngeow, Joanne
    FAMILIAL CANCER, 2020, 19 (02) : 123 - 131
  • [44] PALB2 and breast cancer: ready for clinical translation!
    Southey, Melissa C.
    Teo, Zhi L.
    Winship, Ingrid
    APPLICATION OF CLINICAL GENETICS, 2013, 6 : 43 - 52
  • [45] PALB2—a new player in hereditary breast cancer
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (10) : 560 - 560
  • [46] PALB2, a major susceptibility gene for breast cancer
    Piffer, A.
    Luporsi, E.
    Mathelin, C.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2018, 46 (10-11): : 701 - 705
  • [47] Breast cancer risk in women with PALB2 mutations in diff erent populations
    Antoniou, Antonis C.
    Foulkes, William D.
    Tischkowitz, Marc
    LANCET ONCOLOGY, 2015, 16 (08): : E375 - E376
  • [48] Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis
    Cybulski, Cezary
    Kluzniak, Wojciech
    Huzarski, Tomasz
    Wokolorczyk, Dominika
    Kashyap, Aniruddh
    Jakubowska, Anna
    Szwiec, Marek
    Byrski, Tomasz
    Debniak, Tadeusz
    Gorski, Bohdan
    Sopik, Victoria
    Akbari, Mohammad R.
    Sun, Ping
    Gronwald, Jacek
    Narod, Steven A.
    Lubinski, Jan
    LANCET ONCOLOGY, 2015, 16 (06): : 638 - 644
  • [49] PALB2 is a novel breast cancer susceptibility gene
    Nature Clinical Practice Oncology, 2007, 4 (5): : 271 - 271
  • [50] PALB2 mutations in familial breast and pancreatic cancer
    Hofstatter, Erin W.
    Domchek, Susan M.
    Miron, Alexander
    Garber, Judy
    Wang, Molin
    Componeschi, Kathryn
    Boghossian, Leigh
    Miron, Penelope L.
    Nathanson, Katherine L.
    Tung, Nadine
    FAMILIAL CANCER, 2011, 10 (02) : 225 - 231
12345